Study Country Design Sample size Age at assessment Gestational age group classification Exclusion criteria Assessment tool Cut-off criteria DCD preterm prevalence n (%)
Brown et al., 2015 [19] Australia Cohort study 50-preterm 50 months Extremely preterm IQ <70, congenital anomalies, CP, a visual or hearing impairment MABC-2 ≤15th percentile 15 (30)
Dewey et al., 2019 [20] Australia Cohort study 162-preterm 7 years Very preterm CP MABC-2 <16th percentile 53 (32.7)
Doyley et al., 2014 [21] Multicenter (Canada, Australia, Europe, Israel) Randomized clinical trial 698-preterm (placebo group) 5 years Classification by birth weight IQ ≤69, CP, blindness MABC ≤5th percentile 106 (16.5)
Garbi et al., 2022 [22] France Cross-Sectional 114-preterm 7 to 10 years Extremely preterm Autism, mental delay, CP Touwen Infant Neurological Examination Unclear 12 (11)
Hua et al., 2021 [9]
China
Cohort study
20676-preterm 115376-full-term
3 to 5 years
Very preterm, moderate/late preterm
Visual, hearing, or intellectual impairments or other severe developmental disorders
LDCDQ
≤15th percentile
4326 (20.9)
Kwok et al., 2019 [23] Canada Cohort study 165-preterm 4.5 years Very preterm CP, global developmental delay, intellectual impairment, visual or hearing impairments MABC-2 ≤5th percentile 29 (17.6)
Lahti et al., 2020 [24] Finland Cohort study 37-preterm 11 years Very preterm Congenital anomalies or syndromes, CP, neuromuscular disorders MABC-2 ≤5th percentile 8 (22.2)
Losch, Dammann, 2004 [25] Germany Cohort study 298-preterm 6 years Classification by birth weight CP, ADHD Touwen Infant Neurological Examination Unclear 56 (18.8)
Örtqvist, Einspieler, Ådén, 2021 [26] Sweden Cohort study 32-preterm 12 years Extremely preterm Malformations, chromosome aberrations, malignant disorders, CP, blindness, autism MABC - 2 ≤5th percentile 15 (44)
Setänen et al., 2016 [27] Finland Cohort study 90-preterm 11 years Very preterm Intellectual disability, neurological disorder, CP MABC-2 and DCDQ 07 ≤5th percentile 8 (8.8)
Sustersic, Sustar, Paro-Panjan, 2012 [28] Slovenia Cohort study 41-preterm 5 to 6 years Preterm CP MABC ≤15th percentile 7 (17)
Uusitalo et al., 2020 [29] Finland Cohort study 170-preterm 11 years Very preterm Congenital anomalies, syndrome affecting cognitive development, CP MABC-2 ≤5th percentile 18 (11.2)
Wocadlo, Rieger, 2008 [30] Australia Cohort study 323-preterm 8 yeays Very preterm CP, blindness, hearing impairment, IQ<76, BOTMP < 15th percentile 101 (31.3)
Zamir et al., 2021 [31] Sweden Cohort study 345-preterm 6.5 years Extremely preterm Cerebral palsy MABC-2 ≤5th percentile 76 (22.2)
Zwicker et al., 2013 [32] Canada Cohort study 157-preterm 4 to 5 years Extremely preterm CP, IQ<70, blind MABC ≤15th percentile 65 (42)